Novel CD44-targeting and pH/redox-dual-stimuli-responsive core–shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis
Abstract Background The toxicity and inefficient delivery of triptolide (TPL) in tumor therapy have greatly limited the clinical application. Thus, we fabricated a CD44-targeting and tumor microenvironment pH/redox-sensitive nanosystem composed of hyaluronic acid-vitamin E succinate and poly (β-amin...
Main Authors: | Jinfeng Shi, Yali Ren, Jiaqi Ma, Xi Luo, Jiaxin Li, Yihan Wu, Huan Gu, Chaomei Fu, Zhixing Cao, Jinming Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-021-00934-0 |
Similar Items
-
Identification of a binding target of triptolide and related studies
by: Zhao, Qian, et al.
Published: (2013) -
Advances on Effects of Triptolide with Non-small Cell Lung Cancer
by: Li WANG, et al.
Published: (2013-07-01) -
Triptolide suppresses human synoviocyte MH7A cells mobility and maintains redox balance by inhibiting autophagy
by: Chuanmei Xie, et al.
Published: (2019-07-01) -
ITRAQ-Based Proteomics Analysis of Triptolide On Human A549 Lung Adenocarcinoma Cells
by: Fangqiong Li, et al.
Published: (2018-02-01) -
A review of the total syntheses of triptolide
by: Xiang Zhang, et al.
Published: (2019-08-01)